Prosecution Insights
Last updated: April 19, 2026
Application No. 18/435,767

AQUEOUS EXFOLIATED GRAPHENE BY AMPHIPHILIC CELLULOSE NANOFIBRILS FOR FOLDABLE AND MOISTURE-RESPONSIVE NANOPAPER

Non-Final OA §102§103§112
Filed
Feb 07, 2024
Examiner
FORTUNA, JOSE A
Art Unit
1748
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Regents of the University of California
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
2y 5m
To Grant
89%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
1030 granted / 1299 resolved
+14.3% vs TC avg
Moderate +10% lift
Without
With
+9.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
51 currently pending
Career history
1350
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
44.0%
+4.0% vs TC avg
§102
14.4%
-25.6% vs TC avg
§112
27.9%
-12.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1299 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of group I, claims 10-19 in the reply filed on February 13, 2026 is acknowledged. Claims 20-23 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on February 13, 2026. Specification The disclosure is objected to because of the following informalities: The “CROSS-REFERENCES TO RELATED APPLICATIONS” should be updated. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 11, 13, 15 and 17 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 11, 13, 15 and 17 are vague and indefinite, because the values after the range are considered to be examples, i.e., read as “for example about…” and it has been held that the phrase "for example" renders the claim indefinite because it is unclear whether the limitation(s) following the phrase are part of the claimed invention. See MPEP § 2173.05(d). Note that it is unclear if only those values, the ones after the recited range, are to be considered, i.e., not fraction or values not recited in the numerical set and thus the metes and bounds of patent protection desired cannot be ascertained. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 10-11, 15-16 and 19 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over any of Luon et al., (hereinafter Luong) in “Graphene/cellulose nanocomposite paper with high electrical and mechanical performances,” and Laaksonen et al., (hereinafter Laaksonen), WO 2013/076372 A1. With regard to claim 10 Luong and Laaksonen teach nanopapers comprising graphene and cellulose nanofibrils1; see abstract and preparation of reduced graphene oxide/A-NFC composites on page 13992 of Luong, which teach the use Graphene and NFC, corresponding to the claimed nanofibrils, and Abstract, page 2, lines 23-26, page 7, lines 14-19, page 9, lines 11-12, page 9, lines 27-29 and paragraph bridging pages 10 and 11 of Laaksonen. Regarding to claims 11, Luong discloses thickness of the nanopaper falling within the claimed range; see page 13992 Characterization heading which recites that the thickness is controlled to be about 20 microns. With regard to claims 15-16, Luong teaches graphene addition between 0.3 wt% to 10 wt% which falls within the range of claim 15, while Laaksonen teaches graphene addition from 0.005 to 50 wt% and in the example discloses from 1 wt% through 29 wt% and figures 1A through 1C shows films, i.e., nanopapers having 1 wt%, 5 wt% and 29 wt%; see paragraph bridging pages 11 and 12, which range falls within the range of claims 15 and 16. Regarding to claim 19, since the reference teach the same or very similar nanopaper. having the same components, i.e., graphene and nanofibrils at proportions falling within the claimed range, then such property must be inherently the same. It seems that the references, Luong and Laaksonen, teach all the limitations of the above claims or at the very least the minor modification(s) to obtain the claimed invention would have been obvious to one of ordinary skill in the art. Claims 12-14 and 17-18 are rejected under 35 U.S.C. 103 as being unpatentable over any of Luong and Laaksonen cited above. Both references have been discussed above. They teach the making of a nanopaper or film including graphene and nanofibrils. With regard to claim 12, while the references fail to teach thickness of the nanopaper/composite/film in the range of the claims. Luong teaches that the thickness is controlled to be within 20 microns, which indicates that the thickness of the paper can be controlled to desired level and thus making a paper with the claimed thickness range would have been obvious to one of ordinary skill in the art. Regarding to claims 13-14, None of the references teach the lateral dimension of the graphene, but since the graphene of the references seems to be the same, i.e., made in the same way as disclosed in the current specification; compare ¶-[0051] of the specification with the Experimental section, page 13992, of Luong, paragraph bridging pages 11 and 12 of Laaksonen, such dimension would be considered to be the same or at the very least in ranges falling within the claimed range. With regard to claims 17-18, while the references are silent with regard to the thickness/diameter of the nanofibrils, it is well-known in the art2 that nanofibrils have thickness within the claimed range and thus using nanofibrils having thickness/diameter within such range would be considered obvious to one of ordinary skill in the art, since he/she would have reasonable expectation of success if such known thickness were used in the making of the nanopapers of the cited references, Luong or Laaksonen. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure in the art of “Aqueous Exfoliated Graphene by Amphiphilic Cellulose Nanofibrils for Foldable and Moisture-Responsive Nanopaper.” Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSE A FORTUNA whose telephone number is (571)272-1188. The examiner can normally be reached MONDAY- FRIDAY 11:30 PM- 9:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Abbas Rashid can be reached at 571-270-7457. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSE A FORTUNA/Primary Examiner, Art Unit 1748 JAF 1 Note that cellulose nanofibrils (CNF) is also known as, cellulose nanofibers, microfibrillated Cellulose or MFC, nanofibrillated cellulose or NFC, cellulose fibrils, cellulose nanomaterials or CNMs, cellulose nanowhiskers or CNW 2 The examiner takes official notice of this fact and will present evidence if necessary.
Read full office action

Prosecution Timeline

Feb 07, 2024
Application Filed
Feb 07, 2024
Response after Non-Final Action
Mar 19, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601113
Foam-Based Manufacturing System and Process
2y 5m to grant Granted Apr 14, 2026
Patent 12590418
Sanitary Tissue Products Comprising Once-Dried Fibers
2y 5m to grant Granted Mar 31, 2026
Patent 12590413
WET LAID PAPER AND PAPERBOARD PRODUCTS WITH HIGH WET STRENGTH AND METHOD OF MAKING THE SAME
2y 5m to grant Granted Mar 31, 2026
Patent 12590417
Coreless Rolls of a Tissue Paper Product and Methods of Manufacturing Coreless Rolls
2y 5m to grant Granted Mar 31, 2026
Patent 12590416
BIOBASED BARRIER FILM FOR PACKAGING MATERIAL
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
89%
With Interview (+9.9%)
2y 5m
Median Time to Grant
Low
PTA Risk
Based on 1299 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month